speb/financial-data huggingface dataset:
ACA balance_sheet (annual, 2024-12-31) — Long Term Debt: 1676800000.00
ACA balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 1676800000.00
ACA cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 1635000000.00
ACA cash_flow (quarterly, 2024-12-31) — Long Term Debt Issuance: 700000000.00
ACA cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -502000000.00
ACA balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 1292800000.00
ACA cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: -1337500000.00
ACA cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: -10600000.00
ACA balance_sheet (annual, 2024-12-31) — Net Debt: 1501600000.00
ACA income_statement (annual, 2024-12-31) — Net Income: 93700000.00
ACA income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 93400000.00
ACA income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 93700000.00
ACA income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 93700000.00
ACA income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 93700000.00
ACA cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 93700000.00
ACA income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 93700000.00
ACA income_statement (annual, 2024-12-31) — Net Interest Income: -63400000.00
ACA cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: 1133000000.00
ACA cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: 1133000000.00
ACA income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -63400000.00
ACA cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -23300000.00
ACA cash_flow (quarterly, 2024-12-31) — Net Other Financing Charges: -15100000.00
ACA cash_flow (annual, 2024-12-31) — Net Other Investing Changes: 18300000.00
ACA balance_sheet (annual, 2024-12-31) — Net PPE: 2129400000.00
ACA cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: 18300000.00
ACA cash_flow (quarterly, 2024-12-31) — Net PPE Purchase And Sale: 4300000.00
ACA balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 728700000.00
ACA balance_sheet (annual, 2024-12-31) — Non Current Deferred Assets: 2800000.00
ACA balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 200600000.00
ACA balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Assets: 2800000.00
ACA balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Liabilities: 200600000.00
ACA income_statement (annual, 2024-12-31) — Normalized EBITDA: 395900000.00
ACA income_statement (annual, 2024-12-31) — Normalized Income: 93700000.00
ACA cash_flow (annual, 2024-12-31) — Operating Cash Flow: 502000000.00
ACA cash_flow (annual, 2024-12-31) — Operating Gains Losses: -8200000.00
ACA income_statement (annual, 2024-12-31) — Operating Income: 197600000.00
ACA income_statement (annual, 2024-12-31) — Operating Revenue: 2569900000.00
ACA balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 48776818.00
ACA balance_sheet (annual, 2024-12-31) — Other Current Assets: 56600000.00
ACA balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: -17700000.00
ACA income_statement (annual, 2024-12-31) — Other Income Expense: -4200000.00
ACA balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 338300000.00
ACA cash_flow (annual, 2024-12-31) — Other Non Cash Items: -18800000.00
ACA balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 129800000.00
ACA balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 93900000.00
ACA income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: -4200000.00
ACA income_statement (annual, 2024-12-31) — Other Operating Expenses: -2400000.00
ACA income_statement (annual, 2024-12-31) — Otherunder Preferred Stock Dividend: 300000.00
ACA income_statement (quarterly, 2024-12-31) — Otherunder Preferred Stock Dividend: 0.00
ACA balance_sheet (annual, 2024-12-31) — Payables: 237300000.00
ACA balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 403700000.00
ACA income_statement (annual, 2024-12-31) — Pretax Income: 130000000.00
ACA balance_sheet (annual, 2024-12-31) — Properties: 1111700000.00
ACA cash_flow (annual, 2024-12-31) — Purchase Of Business: -1424100000.00
ACA cash_flow (quarterly, 2024-12-31) — Purchase Of Business: -1209500000.00
ACA balance_sheet (annual, 2024-12-31) — Raw Materials: 147100000.00
ACA balance_sheet (annual, 2024-12-31) — Receivables: 350200000.00
ACA income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 2054700000.00
ACA income_statement (annual, 2024-12-31) — Reconciled Depreciation: 195000000.00
ACA cash_flow (annual, 2024-12-31) — Repayment Of Debt: -502000000.00
ACA cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -10600000.00
ACA balance_sheet (annual, 2024-12-31) — Retained Earnings: 748900000.00
ACA cash_flow (annual, 2024-12-31) — Sale Of Business: 86600000.00
ACA cash_flow (quarterly, 2024-12-31) — Sale Of Business: 200000.00
ACA cash_flow (annual, 2024-12-31) — Sale Of PPE: 18300000.00
ACA cash_flow (quarterly, 2024-12-31) — Sale Of PPE: 4300000.00
ACA income_statement (annual, 2024-12-31) — Selling General And Administration: 320000000.00
ACA balance_sheet (annual, 2024-12-31) — Share Issued: 48776818.00
ACA income_statement (annual, 2024-12-31) — Special Income Charges: 2400000.00
ACA income_statement (quarterly, 2024-12-31) — Special Income Charges: 3300000.00
ACA cash_flow (annual, 2024-12-31) — Stock Based Compensation: 24300000.00
ACA balance_sheet (annual, 2024-12-31) — Stockholders Equity: 2428200000.00
ACA balance_sheet (annual, 2024-12-31) — Tangible Book Value: 728700000.00
ACA income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
ACA income_statement (annual, 2024-12-31) — Tax Provision: 36300000.00
ACA income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.28
ACA balance_sheet (annual, 2024-12-31) — Total Assets: 4915500000.00
ACA balance_sheet (annual, 2024-12-31) — Total Capitalization: 4105000000.00
ACA balance_sheet (annual, 2024-12-31) — Total Debt: 1688900000.00
ACA balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 2428200000.00
ACA income_statement (annual, 2024-12-31) — Total Expenses: 2372300000.00
ACA balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 2487300000.00
ACA balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 3961500000.00
ACA balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 1971300000.00
ACA income_statement (annual, 2024-12-31) — Total Operating Income As Reported: 197600000.00
ACA income_statement (annual, 2024-12-31) — Total Unusual Items: -1900000.00
ACA income_statement (quarterly, 2024-12-31) — Total Unusual Items: 4500000.00
ACA income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -1900000.00
ACA income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: 4500000.00
ACA balance_sheet (annual, 2024-12-31) — Work In Process: 36200000.00
ACA balance_sheet (annual, 2024-12-31) — Working Capital: 438000000.00
ACA income_statement (annual, 2024-12-31) — Write Off: 5800000.00
ACA income_statement (quarterly, 2024-12-31) — Write Off: 0.00
ACA income_statement (quarterly, 2025-03-31) — +Operating Expense: 66900000.00
ACA income_statement (quarterly, 2025-03-31) — +Total Revenue: 547600000.00
ACA balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 283500000.00
ACA balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 427600000.00
ACA balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -971000000.00
ACA balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 1703300000.00
ACA income_statement (quarterly, 2025-03-31) — Average Dilution Earnings: 0.00
ACA income_statement (quarterly, 2025-03-31) — Basic Average Shares: 48700000.00
ACA income_statement (quarterly, 2025-03-31) — Basic EPS: 0.48
ACA cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 187300000.00
ACA balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 369800000.00
ACA cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -33000000.00
ACA cash_flow (quarterly, 2025-03-31) — Capital Expenditure Reported: -33000000.00
ACA balance_sheet (quarterly, 2025-03-31) — Capital Stock: 500000.00
ACA balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 167900000.00
ACA balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 167900000.00
ACA cash_flow (quarterly, 2025-03-31) — Cash Dividends Paid: -2500000.00
ACA cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -7300000.00
ACA cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -10400000.00
ACA cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -21100000.00
ACA cash_flow (quarterly, 2025-03-31) — Cash From Discontinued Investing Activities: -1000000.00
ACA cash_flow (quarterly, 2025-03-31) — Cash From Discontinued Operating Activities: 20400000.00
ACA cash_flow (quarterly, 2025-03-31) — Change In Account Payable: 43800000.00
ACA cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: -19100000.00
ACA cash_flow (quarterly, 2025-03-31) — Change In Inventory: -4100000.00
ACA cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: 5900000.00
ACA cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: -43900000.00
ACA cash_flow (quarterly, 2025-03-31) — Change In Payable: 43800000.00
ACA cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: 24700000.00
ACA cash_flow (quarterly, 2025-03-31) — Change In Receivables: -70700000.00
ACA cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -88100000.00
ACA cash_flow (quarterly, 2025-03-31) — Changes In Cash: -19400000.00
ACA balance_sheet (quarterly, 2025-03-31) — Common Stock: 500000.00
ACA cash_flow (quarterly, 2025-03-31) — Common Stock Dividend Paid: -2500000.00
ACA balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 2454500000.00
ACA cash_flow (quarterly, 2025-03-31) — Common Stock Payments: -1500000.00
ACA balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 124500000.00
ACA income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 439700000.00
ACA balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 144100000.00
ACA balance_sheet (quarterly, 2025-03-31) — Current Assets: 1011300000.00
ACA balance_sheet (quarterly, 2025-03-31) — Current Debt: 11200000.00
ACA balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 11200000.00
ACA balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 71200000.00
ACA balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 71200000.00
ACA balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 510000000.00
ACA cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: 900000.00
ACA cash_flow (quarterly, 2025-03-31) — Deferred Tax: 900000.00
ACA cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 51700000.00
ACA income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 49200000.00
ACA income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.48
ACA income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 23500000.00
ACA income_statement (quarterly, 2025-03-31) — EBIT: 42700000.00
ACA income_statement (quarterly, 2025-03-31) — EBITDA: 94400000.00
ACA cash_flow (quarterly, 2025-03-31) — End Cash Position: 167900000.00
ACA cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -7300000.00
ACA balance_sheet (quarterly, 2025-03-31) — Finished Goods: 181900000.00
ACA cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -33700000.00
ACA cash_flow (quarterly, 2025-03-31) — Gain Loss On Sale Of Business: -300000.00
ACA cash_flow (quarterly, 2025-03-31) — Gain Loss On Sale Of PPE: -3800000.00
ACA income_statement (quarterly, 2025-03-31) — Gain On Sale Of Business: 300000.00
ACA income_statement (quarterly, 2025-03-31) — Gain On Sale Of Ppe: 3800000.00
ACA income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: -100000.00
ACA balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -17700000.00
ACA balance_sheet (quarterly, 2025-03-31) — Goodwill: 1343200000.00
ACA balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 1674200000.00
ACA balance_sheet (quarterly, 2025-03-31) — Gross PPE: 3088900000.00
ACA income_statement (quarterly, 2025-03-31) — Gross Profit: 107900000.00
ACA income_statement (quarterly, 2025-03-31) — Interest Expense: 28300000.00
ACA income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 28300000.00
ACA income_statement (quarterly, 2025-03-31) — Interest Income: 1800000.00
ACA income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 1800000.00
ACA balance_sheet (quarterly, 2025-03-31) — Inventory: 365000000.00
ACA balance_sheet (quarterly, 2025-03-31) — Invested Capital: 4140800000.00
ACA cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -11400000.00
ACA cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 0.00
ACA balance_sheet (quarterly, 2025-03-31) — Land And Improvements: 158000000.00
ACA balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 1675100000.00
ACA balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 1675100000.00
ACA cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 0.00
ACA cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -3300000.00
ACA balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 1323400000.00
ACA cash_flow (quarterly, 2025-03-31) — Net Business Purchase And Sale: 17600000.00
ACA cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: -1500000.00
ACA balance_sheet (quarterly, 2025-03-31) — Net Debt: 1518400000.00
ACA income_statement (quarterly, 2025-03-31) — Net Income: 23600000.00
ACA income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 23500000.00
ACA income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 11600000.00
ACA income_statement (quarterly, 2025-03-31) — Net Income Discontinuous Operations: 12000000.00
ACA income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 23600000.00
ACA income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 11600000.00
ACA cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 11600000.00
ACA income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 23600000.00
ACA income_statement (quarterly, 2025-03-31) — Net Interest Income: -26500000.00
ACA cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: -3300000.00
ACA cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: -3300000.00
ACA income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -26500000.00
ACA cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: 5000000.00
ACA balance_sheet (quarterly, 2025-03-31) — Net PPE: 2117900000.00
ACA cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: 5000000.00
ACA balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 780300000.00
ACA balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Assets: 2800000.00
ACA balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 202800000.00
ACA balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 2800000.00
ACA balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 202800000.00
ACA income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 94400000.00
ACA income_statement (quarterly, 2025-03-31) — Normalized Income: 11600000.00
ACA cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -700000.00
ACA cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: -4100000.00
ACA income_statement (quarterly, 2025-03-31) — Operating Income: 41000000.00
ACA income_statement (quarterly, 2025-03-31) — Operating Revenue: 547600000.00
ACA balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 48775761.00
ACA balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 50800000.00
ACA balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -17700000.00
ACA income_statement (quarterly, 2025-03-31) — Other Income Expense: -100000.00
ACA balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 331000000.00
ACA cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 500000.00
ACA balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 127700000.00
ACA balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 91500000.00
ACA income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: -100000.00
ACA income_statement (quarterly, 2025-03-31) — Other Operating Expenses: -4100000.00
ACA income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 100000.00
ACA balance_sheet (quarterly, 2025-03-31) — Payables: 283500000.00
ACA balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 427600000.00
ACA income_statement (quarterly, 2025-03-31) — Pretax Income: 14400000.00
ACA balance_sheet (quarterly, 2025-03-31) — Properties: 1113200000.00
ACA balance_sheet (quarterly, 2025-03-31) — Raw Materials: 152300000.00
ACA balance_sheet (quarterly, 2025-03-31) — Receivables: 427600000.00
ACA income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 439700000.00
ACA income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 51700000.00
ACA cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -3300000.00
ACA cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: -1500000.00
ACA balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 770000000.00
ACA cash_flow (quarterly, 2025-03-31) — Sale Of Business: 17600000.00
ACA cash_flow (quarterly, 2025-03-31) — Sale Of PPE: 5000000.00
ACA income_statement (quarterly, 2025-03-31) — Selling General And Administration: 71000000.00
ACA balance_sheet (quarterly, 2025-03-31) — Share Issued: 48775761.00
ACA income_statement (quarterly, 2025-03-31) — Special Income Charges: 4100000.00
ACA cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 6400000.00
ACA balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 2454500000.00
ACA balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 780300000.00
ACA income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
ACA income_statement (quarterly, 2025-03-31) — Tax Provision: 2800000.00
ACA income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.19
ACA balance_sheet (quarterly, 2025-03-31) — Total Assets: 4933900000.00
ACA balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 4129600000.00
ACA balance_sheet (quarterly, 2025-03-31) — Total Debt: 1686300000.00
ACA balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 2454500000.00
ACA income_statement (quarterly, 2025-03-31) — Total Expenses: 506600000.00
ACA balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 2479400000.00
ACA balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 3922600000.00
ACA balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 1969400000.00
ACA income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: 41000000.00
ACA income_statement (quarterly, 2025-03-31) — Total Unusual Items: 4000000.00
ACA income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 4000000.00
ACA balance_sheet (quarterly, 2025-03-31) — Treasury Stock: 1600000.00
ACA balance_sheet (quarterly, 2025-03-31) — Work In Process: 30800000.00
ACA balance_sheet (quarterly, 2025-03-31) — Working Capital: 501300000.00
ACA income_statement (quarterly, 2025-06-30) — +Operating Expense: 73000000.00
ACA income_statement (quarterly, 2025-06-30) — +Total Revenue: 736900000.00
ACA balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 297500000.00
ACA balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 477000000.00
ACA balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -1015300000.00
ACA balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 1697400000.00
ACA income_statement (quarterly, 2025-06-30) — Average Dilution Earnings: 0.00
ACA income_statement (quarterly, 2025-06-30) — Basic Average Shares: 48900000.00
ACA income_statement (quarterly, 2025-06-30) — Basic EPS: 1.22
ACA cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 167900000.00
ACA balance_sheet (quarterly, 2025-06-30) — Buildings And Improvements: 391400000.00
ACA cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -28800000.00
ACA cash_flow (quarterly, 2025-06-30) — Capital Expenditure Reported: -28800000.00
ACA balance_sheet (quarterly, 2025-06-30) — Capital Stock: 500000.00
ACA balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 189700000.00
ACA balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 189700000.00
ACA cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: -2500000.00
ACA cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -17400000.00
ACA cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -23000000.00
ACA cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 81600000.00
ACA cash_flow (quarterly, 2025-06-30) — Change In Account Payable: 16300000.00
ACA cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: 8100000.00
ACA cash_flow (quarterly, 2025-06-30) — Change In Inventory: -46600000.00
ACA cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: 7500000.00
ACA cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: 2100000.00
ACA cash_flow (quarterly, 2025-06-30) — Change In Payable: 16300000.00
ACA cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 24400000.00
ACA cash_flow (quarterly, 2025-06-30) — Change In Receivables: -55600000.00
ACA cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -68200000.00
ACA cash_flow (quarterly, 2025-06-30) — Changes In Cash: 21800000.00
ACA balance_sheet (quarterly, 2025-06-30) — Common Stock: 500000.00
ACA cash_flow (quarterly, 2025-06-30) — Common Stock Dividend Paid: -2500000.00
ACA balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 2508300000.00
ACA cash_flow (quarterly, 2025-06-30) — Common Stock Payments: -10900000.00
ACA balance_sheet (quarterly, 2025-06-30) — Construction In Progress: 129200000.00
ACA income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 570800000.00
ACA balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 161400000.00
ACA balance_sheet (quarterly, 2025-06-30) — Current Assets: 1116700000.00
ACA balance_sheet (quarterly, 2025-06-30) — Current Debt: 10200000.00
ACA balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 10200000.00
ACA balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 58400000.00
ACA balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 58400000.00
ACA balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 527500000.00
ACA cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: 11000000.00
ACA cash_flow (quarterly, 2025-06-30) — Deferred Tax: 11000000.00
ACA cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 58000000.00
ACA income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 49000000.00
ACA income_statement (quarterly, 2025-06-30) — Diluted EPS: 1.22
ACA income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 59600000.00
ACA income_statement (quarterly, 2025-06-30) — EBIT: 98300000.00
ACA income_statement (quarterly, 2025-06-30) — EBITDA: 156300000.00
ACA cash_flow (quarterly, 2025-06-30) — End Cash Position: 189700000.00
ACA cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -17400000.00
ACA balance_sheet (quarterly, 2025-06-30) — Finished Goods: 188900000.00
ACA cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 32400000.00
ACA cash_flow (quarterly, 2025-06-30) — Gain Loss On Sale Of Business: 2800000.00
ACA cash_flow (quarterly, 2025-06-30) — Gain Loss On Sale Of PPE: -4500000.00
ACA income_statement (quarterly, 2025-06-30) — Gain On Sale Of Business: -2800000.00
ACA income_statement (quarterly, 2025-06-30) — Gain On Sale Of Ppe: 4500000.00
ACA income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: 2200000.00
ACA balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -16800000.00
ACA balance_sheet (quarterly, 2025-06-30) — Goodwill: 1343400000.00
ACA balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 1667600000.00
ACA balance_sheet (quarterly, 2025-06-30) — Gross PPE: 3116200000.00
ACA income_statement (quarterly, 2025-06-30) — Gross Profit: 166100000.00
ACA income_statement (quarterly, 2025-06-30) — Interest Expense: 28500000.00
ACA income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 28500000.00
ACA income_statement (quarterly, 2025-06-30) — Interest Income: 1300000.00
ACA income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 1300000.00
ACA balance_sheet (quarterly, 2025-06-30) — Inventory: 406800000.00
ACA balance_sheet (quarterly, 2025-06-30) — Invested Capital: 4191800000.00
ACA cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -22000000.00
ACA cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 0.00
ACA balance_sheet (quarterly, 2025-06-30) — Land And Improvements: 170000000.00
ACA balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 1673300000.00
ACA balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 1673300000.00
ACA cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: 0.00
ACA cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -3300000.00
ACA balance_sheet (quarterly, 2025-06-30) — Machinery Furniture Equipment: 1308200000.00
ACA cash_flow (quarterly, 2025-06-30) — Net Business Purchase And Sale: 0.00
ACA cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: -10900000.00
ACA balance_sheet (quarterly, 2025-06-30) — Net Debt: 1493800000.00
ACA income_statement (quarterly, 2025-06-30) — Net Income: 59700000.00
ACA income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 59600000.00
ACA income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 59700000.00
ACA income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 59700000.00
ACA income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 59700000.00
ACA cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 71700000.00
ACA income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 59700000.00
ACA income_statement (quarterly, 2025-06-30) — Net Interest Income: -27200000.00
ACA cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: -3300000.00
ACA cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: -3300000.00
ACA income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -27200000.00
ACA balance_sheet (quarterly, 2025-06-30) — Net PPE: 2100900000.00
ACA cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: 5800000.00
ACA balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 840700000.00
ACA balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Assets: 2600000.00
ACA balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 212500000.00
ACA balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Assets: 2600000.00
ACA balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 212500000.00
ACA income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 152400000.00
ACA income_statement (quarterly, 2025-06-30) — Normalized Income: 56365500.00
ACA cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 61200000.00
ACA cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: -1700000.00
ACA income_statement (quarterly, 2025-06-30) — Operating Income: 93100000.00
ACA income_statement (quarterly, 2025-06-30) — Operating Revenue: 736900000.00
ACA balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 49044906.00
ACA balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 43200000.00
ACA balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -16800000.00
ACA income_statement (quarterly, 2025-06-30) — Other Income Expense: 3900000.00
ACA balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 324200000.00
ACA cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 3800000.00
ACA balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 123800000.00
ACA balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 90000000.00
ACA income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 100000.00
ACA balance_sheet (quarterly, 2025-06-30) — Payables: 297500000.00
ACA balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 458900000.00
ACA income_statement (quarterly, 2025-06-30) — Pretax Income: 69800000.00
ACA balance_sheet (quarterly, 2025-06-30) — Properties: 1117400000.00
ACA balance_sheet (quarterly, 2025-06-30) — Raw Materials: 179400000.00
ACA balance_sheet (quarterly, 2025-06-30) — Receivables: 477000000.00
ACA income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 570800000.00
ACA income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 58000000.00
ACA cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -3300000.00
ACA cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: -10900000.00
ACA balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 827200000.00
ACA cash_flow (quarterly, 2025-06-30) — Sale Of Business: 0.00
ACA cash_flow (quarterly, 2025-06-30) — Sale Of PPE: 5800000.00
ACA income_statement (quarterly, 2025-06-30) — Selling General And Administration: 73000000.00
ACA balance_sheet (quarterly, 2025-06-30) — Share Issued: 49044906.00
ACA income_statement (quarterly, 2025-06-30) — Special Income Charges: 1700000.00
ACA cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 7000000.00
ACA balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 2508300000.00
ACA balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 840700000.00
ACA income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 565500.00
ACA income_statement (quarterly, 2025-06-30) — Tax Provision: 10100000.00
ACA income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.15
ACA balance_sheet (quarterly, 2025-06-30) — Total Assets: 5011600000.00
ACA balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 4181600000.00
ACA balance_sheet (quarterly, 2025-06-30) — Total Debt: 1683500000.00
ACA balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 2508300000.00
ACA income_statement (quarterly, 2025-06-30) — Total Expenses: 643800000.00
ACA balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 2503300000.00
ACA balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 3894900000.00
ACA balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 1975800000.00
ACA income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: 94800000.00
ACA income_statement (quarterly, 2025-06-30) — Total Unusual Items: 3900000.00
ACA income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 3900000.00
ACA balance_sheet (quarterly, 2025-06-30) — Treasury Stock: 0.00
ACA balance_sheet (quarterly, 2025-06-30) — Work In Process: 38500000.00
ACA balance_sheet (quarterly, 2025-06-30) — Working Capital: 589200000.00
ACA income_statement (quarterly, 2025-06-30) — Write Off: 0.00
ACA income_statement (quarterly, 2025-09-30) — +Operating Expense: 79600000.00
ACA income_statement (quarterly, 2025-09-30) — +Total Revenue: 797800000.00
ACA balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 319300000.00
ACA balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 480300000.00
ACA balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -1050400000.00
ACA balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 1703900000.00
ACA cash_flow (quarterly, 2025-09-30) — Asset Impairment Charge: 2000000.00
ACA income_statement (quarterly, 2025-09-30) — Basic Average Shares: 49000000.00
ACA income_statement (quarterly, 2025-09-30) — Basic EPS: 1.49
ACA cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 189700000.00
ACA balance_sheet (quarterly, 2025-09-30) — Buildings And Improvements: 397500000.00
ACA cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -39600000.00
ACA cash_flow (quarterly, 2025-09-30) — Capital Expenditure Reported: -39600000.00
ACA balance_sheet (quarterly, 2025-09-30) — Capital Stock: 500000.00
ACA balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 220000000.00
ACA balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 220000000.00
ACA cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: -2500000.00
ACA cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -103700000.00
ACA cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -26600000.00
ACA cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 160600000.00
ACA cash_flow (quarterly, 2025-09-30) — Change In Account Payable: 21800000.00
ACA cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: 10300000.00
ACA cash_flow (quarterly, 2025-09-30) — Change In Inventory: -9300000.00
ACA cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: -8000000.00
ACA cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: 12900000.00
ACA cash_flow (quarterly, 2025-09-30) — Change In Payable: 21800000.00
ACA cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 32100000.00
ACA cash_flow (quarterly, 2025-09-30) — Change In Receivables: -5000000.00
ACA cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 22700000.00
ACA cash_flow (quarterly, 2025-09-30) — Changes In Cash: 30300000.00
ACA balance_sheet (quarterly, 2025-09-30) — Common Stock: 500000.00
ACA cash_flow (quarterly, 2025-09-30) — Common Stock Dividend Paid: -2500000.00
ACA balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 2584900000.00
ACA cash_flow (quarterly, 2025-09-30) — Common Stock Payments: 0.00
ACA balance_sheet (quarterly, 2025-09-30) — Construction In Progress: 127800000.00
ACA income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 605900000.00
ACA balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 179800000.00
ACA balance_sheet (quarterly, 2025-09-30) — Current Assets: 1172200000.00
ACA balance_sheet (quarterly, 2025-09-30) — Current Debt: 9300000.00
ACA balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 9300000.00
ACA balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 71300000.00
ACA balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 71300000.00
ACA balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 579700000.00
ACA cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: 9600000.00
ACA cash_flow (quarterly, 2025-09-30) — Deferred Tax: 9600000.00
ACA cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 56200000.00
ACA income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 49100000.00
ACA income_statement (quarterly, 2025-09-30) — Diluted EPS: 1.48
ACA income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 73000000.00
ACA income_statement (quarterly, 2025-09-30) — EBIT: 114200000.00
ACA income_statement (quarterly, 2025-09-30) — EBITDA: 170400000.00
ACA cash_flow (quarterly, 2025-09-30) — End Cash Position: 220000000.00
ACA cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -103700000.00
ACA balance_sheet (quarterly, 2025-09-30) — Finished Goods: 196600000.00
ACA cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 121000000.00
ACA income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: 100000.00
ACA balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -17100000.00
ACA balance_sheet (quarterly, 2025-09-30) — Goodwill: 1348900000.00
ACA balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 1666500000.00
ACA balance_sheet (quarterly, 2025-09-30) — Gross PPE: 3138500000.00
ACA income_statement (quarterly, 2025-09-30) — Gross Profit: 191900000.00
ACA income_statement (quarterly, 2025-09-30) — Interest Expense: 27100000.00
ACA income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 27100000.00
ACA income_statement (quarterly, 2025-09-30) — Interest Income: 1800000.00
ACA income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 1800000.00
ACA balance_sheet (quarterly, 2025-09-30) — Inventory: 420700000.00
ACA balance_sheet (quarterly, 2025-09-30) — Invested Capital: 4168000000.00
ACA cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -26600000.00
ACA cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 0.00
ACA balance_sheet (quarterly, 2025-09-30) — Land And Improvements: 167500000.00
ACA balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 1573800000.00
ACA balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 1573800000.00
ACA cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: 0.00
ACA cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -101100000.00
ACA balance_sheet (quarterly, 2025-09-30) — Machinery Furniture Equipment: 1331200000.00
ACA cash_flow (quarterly, 2025-09-30) — Net Business Purchase And Sale: 0.00
ACA cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 0.00
ACA balance_sheet (quarterly, 2025-09-30) — Net Debt: 1363100000.00
ACA income_statement (quarterly, 2025-09-30) — Net Income: 73000000.00
ACA income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 73000000.00
ACA income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 73000000.00
ACA income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 73000000.00
ACA income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 73000000.00
ACA cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 73000000.00
ACA income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 73000000.00
ACA income_statement (quarterly, 2025-09-30) — Net Interest Income: -25300000.00
ACA cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -101100000.00
ACA cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: -101100000.00
ACA income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -25300000.00
ACA cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -100000.00
ACA balance_sheet (quarterly, 2025-09-30) — Net PPE: 2088100000.00
ACA balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 918400000.00
ACA balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Assets: 2600000.00
ACA balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 220900000.00
ACA balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 2600000.00
ACA balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 220900000.00
ACA income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 170300000.00
ACA income_statement (quarterly, 2025-09-30) — Normalized Income: 72916200.00
ACA cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 160600000.00
ACA cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: -4600000.00
ACA income_statement (quarterly, 2025-09-30) — Operating Income: 112300000.00
ACA income_statement (quarterly, 2025-09-30) — Operating Revenue: 797800000.00
ACA balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 49100000.00
ACA balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 51200000.00
ACA balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -17100000.00
ACA income_statement (quarterly, 2025-09-30) — Other Income Expense: 100000.00
ACA balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 317600000.00
ACA cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: -4700000.00
ACA balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 123600000.00
ACA balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 93700000.00
ACA income_statement (quarterly, 2025-09-30) — Other Operating Expenses: -2600000.00
ACA balance_sheet (quarterly, 2025-09-30) — Payables: 319300000.00
ACA balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 499100000.00
ACA income_statement (quarterly, 2025-09-30) — Pretax Income: 87100000.00
ACA balance_sheet (quarterly, 2025-09-30) — Properties: 1114500000.00
ACA balance_sheet (quarterly, 2025-09-30) — Raw Materials: 177400000.00
ACA balance_sheet (quarterly, 2025-09-30) — Receivables: 480300000.00
ACA income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 605900000.00
ACA income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 56200000.00
ACA cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -101100000.00
ACA cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: 0.00
ACA balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 897700000.00
ACA cash_flow (quarterly, 2025-09-30) — Sale Of Business: 0.00
ACA income_statement (quarterly, 2025-09-30) — Selling General And Administration: 82200000.00
ACA balance_sheet (quarterly, 2025-09-30) — Share Issued: 49100000.00
ACA cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 6400000.00
ACA balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 2584900000.00
ACA balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 918400000.00
ACA income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 16200.00
ACA income_statement (quarterly, 2025-09-30) — Tax Provision: 14100000.00
ACA income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.16
ACA balance_sheet (quarterly, 2025-09-30) — Total Assets: 5053000000.00
ACA balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 4158700000.00
ACA balance_sheet (quarterly, 2025-09-30) — Total Debt: 1583100000.00
ACA balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 2584900000.00
ACA income_statement (quarterly, 2025-09-30) — Total Expenses: 685500000.00
ACA balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 2468100000.00
ACA balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 3880800000.00
ACA balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 1888400000.00
ACA income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: 112300000.00
ACA income_statement (quarterly, 2025-09-30) — Total Unusual Items: 100000.00
ACA income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 100000.00
ACA balance_sheet (quarterly, 2025-09-30) — Treasury Stock: 100000.00
ACA balance_sheet (quarterly, 2025-09-30) — Work In Process: 46700000.00
ACA balance_sheet (quarterly, 2025-09-30) — Working Capital: 592500000.00
ACA income_statement (annual, 2025-12-31) — +Operating Expense: 305300000.00
ACA income_statement (quarterly, 2025-12-31) — +Operating Expense: 84800000.00
ACA income_statement (annual, 2025-12-31) — +Total Revenue: 2883400000.00
ACA income_statement (quarterly, 2025-12-31) — +Total Revenue: 716700000.00
ACA balance_sheet (annual, 2025-12-31) — Accounts Payable: 259300000.00
ACA balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 259300000.00
ACA balance_sheet (annual, 2025-12-31) — Accounts Receivable: 417700000.00
ACA balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 417700000.00
ACA balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -1086800000.00
ACA balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -1086800000.00
ACA balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 1710000000.00
ACA balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 1710000000.00
ACA balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -9600000.00
ACA balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -9600000.00
ACA cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 1600000.00
ACA cash_flow (quarterly, 2025-12-31) — Asset Impairment Charge: -400000.00
ACA income_statement (annual, 2025-12-31) — Average Dilution Earnings: 0.00
ACA income_statement (annual, 2025-12-31) — Basic Average Shares: 48900000.00
ACA income_statement (quarterly, 2025-12-31) — Basic Average Shares: 49000000.00
ACA income_statement (annual, 2025-12-31) — Basic EPS: 4.25
ACA income_statement (quarterly, 2025-12-31) — Basic EPS: 1.06
ACA cash_flow (annual, 2025-12-31) — Beginning Cash Position: 187300000.00
ACA cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 220000000.00
ACA balance_sheet (annual, 2025-12-31) — Buildings And Improvements: 443500000.00
ACA balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 443500000.00
ACA cash_flow (annual, 2025-12-31) — Capital Expenditure: -165600000.00
ACA cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -64200000.00
ACA cash_flow (annual, 2025-12-31) — Capital Expenditure Reported: -165600000.00
ACA cash_flow (quarterly, 2025-12-31) — Capital Expenditure Reported: -64200000.00
ACA balance_sheet (annual, 2025-12-31) — Capital Stock: 500000.00
ACA balance_sheet (quarterly, 2025-12-31) — Capital Stock: 500000.00
ACA balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 214600000.00
ACA balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 214600000.00
ACA balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 214600000.00
ACA balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 214600000.00
ACA cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -10000000.00
ACA cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: -2500000.00
ACA cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -192400000.00
ACA cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -64000000.00
ACA cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -121400000.00
ACA cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -61400000.00
ACA cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 341100000.00
ACA cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 120000000.00
ACA cash_flow (annual, 2025-12-31) — Change In Account Payable: 21900000.00
ACA cash_flow (quarterly, 2025-12-31) — Change In Account Payable: -60000000.00
ACA cash_flow (annual, 2025-12-31) — Change In Accrued Expense: 2500000.00
ACA cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: 3200000.00
ACA cash_flow (annual, 2025-12-31) — Change In Inventory: -72600000.00
ACA cash_flow (quarterly, 2025-12-31) — Change In Inventory: -12600000.00
ACA cash_flow (annual, 2025-12-31) — Change In Other Current Assets: 6400000.00
ACA cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: 1000000.00
ACA cash_flow (annual, 2025-12-31) — Change In Other Working Capital: -43200000.00
ACA cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: -14300000.00
ACA cash_flow (annual, 2025-12-31) — Change In Payable: 21900000.00
ACA cash_flow (quarterly, 2025-12-31) — Change In Payable: -60000000.00
ACA cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 24400000.00
ACA cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: -56800000.00
ACA cash_flow (annual, 2025-12-31) — Change In Receivables: -69500000.00
ACA cash_flow (quarterly, 2025-12-31) — Change In Receivables: 61800000.00
ACA cash_flow (annual, 2025-12-31) — Change In Working Capital: -154500000.00
ACA cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -20900000.00